We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Travelers Companies
TRV
$82.9B
| $68.1M | 0.16% |
565,013
+20,921
| +4% | +$2.51M |
|
127
Cigna
CI
$79.6B
| $67.6M | 0.16% |
461,610
+12,945
| +3% | +$1.91M |
|
128
Public Storage
PSA
$61.7B
| $67.2M | 0.16% |
306,998
+15,661
| +5% | +$3.47M |
|
129
Applied Materials
AMAT
$378B
| $67.2M | 0.16% |
1,726,738
+39,847
| +2% | +$1.43M |
|
130
Johnson Controls International
JCI
$85.6B
| $66.3M | 0.15% |
1,573,956
-8,140
| -0.5% | -$344K |
|
131
Crown Castle
CCI
$33.1B
| $65.3M | 0.15% |
691,332
+34,834
| +5% | +$3.12M |
|
132
Phillips 66
PSX
$82.5B
| $63.6M | 0.15% |
802,782
+21,447
| +3% | +$1.73M |
|
133
Deere & Co
DE
$173B
| $63.5M | 0.15% |
582,970
+23,304
| +4% | +$2.52M |
|
|
PX
134
DELISTED
Praxair Inc
PX
| $62.8M | 0.15% |
529,682
+5,939
| +1% | +$698K |
|
135
General Mills
GIS
$20.1B
| $62.8M | 0.15% |
1,064,251
+15,612
| +1% | +$954K |
|
136
Truist Financial
TFC
$64.7B
| $62M | 0.14% |
1,386,223
+35,731
| +3% | +$1.67M |
|
137
Ecolab
ECL
$79.6B
| $61.7M | 0.14% |
492,510
+9,028
| +2% | +$1.1M |
|
138
Norfolk Southern
NSC
$76.1B
| $60.9M | 0.14% |
543,944
+6,584
| +1% | +$770K |
|
139
Intercontinental Exchange
ICE
$86.4B
| $60.9M | 0.14% |
1,016,922
+17,338
| +2% | +$1.01M |
|
140
Equinix
EQIX
$102B
| $60.4M | 0.14% |
150,735
+9,081
| +6% | +$3.45M |
|
141
Becton Dickinson
BDX
$45.8B
| $60.2M | 0.14% |
336,355
+6,768
| +2% | +$1.18M |
|
142
Valero Energy
VLO
$88.7B
| $59.8M | 0.14% |
902,108
-45,622
| -5% | -$3.05M |
|
|
APC
143
DELISTED
Anadarko Petroleum
APC
| $59.6M | 0.14% |
961,590
+34,267
| +4% | +$2.28M |
|
144
Allstate
ALL
$70.1B
| $59.5M | 0.14% |
729,620
+55,841
| +8% | +$4.39M |
|
145
Southwest Airlines
LUV
$22.7B
| $59.3M | 0.14% |
1,102,349
+73,910
| +7% | +$3.97M |
|
146
Cognizant
CTSH
$23.8B
| $59.2M | 0.14% |
994,246
+18,477
| +2% | +$1.06M |
|
147
Marriott International
MAR
$101B
| $59.1M | 0.14% |
627,179
+16,741
| +3% | +$1.45M |
|
|
TFCFA
148
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $58.7M | 0.14% |
1,812,483
-46,726
| -3% | -$1.43M |
|
149
American Electric Power
AEP
$72.4B
| $58.5M | 0.14% |
871,723
+26,321
| +3% | +$1.7M |
|
150
Intuitive Surgical
ISRG
$130B
| $58.4M | 0.14% |
685,431
+21,321
| +3% | +$1.68M |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.